Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

81. For uncomplicated urinary tract infections, is symptomatic management alone non-inferior to antimicrobial treatment? A systematic review and meta-analysis of randomized controlled trials

For uncomplicated urinary tract infections, is symptomatic management alone non-inferior to antimicrobial treatment? A systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2018 PROSPERO

82. Prevalence of urinary tract infection in Iranian renal transplant patients

Prevalence of urinary tract infection in Iranian renal transplant patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2018 PROSPERO

83. Point-of-care tests for urinary tract infections: diagnostic test accuracy systematic review and meta-analysis

Point-of-care tests for urinary tract infections: diagnostic test accuracy systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

84. Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness

Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness | CADTH.ca Find the information you need Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness Last updated: April 12, 2018 Project Number: RB1210-000 Product Line: Research Type: Drug (...) Report Type: Summary of Abstracts Result type: Report Question What is the comparative clinical effectiveness of fosfomycin compared with other antibiotics for the treatment of lower urinary tract infections? What is the comparative cost effectiveness of fosfomycin compared with other antibiotics for the treatment of lower urinary tract infections? Key Message Two non-randomized studies and one economic evaluation were identified regarding the use of Fosfomycin for the treatment of lower urinary

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

85. Urinary Tract Infection (Cystitis) - acute, uncomplicated

Urinary Tract Infection (Cystitis) - acute, uncomplicated Urinary Tract Infection (Cystitis) - acute, uncomplicated - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Urinary Tract Infection (Cystitis) - acute, uncomplicated An acute infection of the bladder (acute cystitis) Most commonly caused by Escherichia coli (80%), with the remaining 20 % caused by Staphylococcus species , proteus mirabilis, and enterococci Incidence (...) : Uncomplicated UTI : an infection caused by the usual pathogens in a patient with a normal urinary tract and with normal kidney function Complicated UTI : infection in a patient with risk factors for a severe infection or sequalae. All complicated UTIs must be referred. Examples include: Abnormal urinary tract due to an indwelling catheter, urinary obstruction or neurogenic bladder Immunosuppression (due to medications or health conditions, including poorly controlled diabetes) Impaired renal function All

2018 medSask

86. Urinary tract infection (lower) - men

Urinary tract infection (lower) - men Urinary tract infection (lower) - men - NICE CKS Share Urinary tract infection (lower) - men: Summary Urinary tract infection (UTI) is infection of any part of the urinary tract, usually by bacteria. The commonest uropathogen causing UTI in adults is Escherichia coli in approximately 80% of cases. UTI in men is generally uncommon, but incidence rates are higher in elderly men and those with risk factors, such as: Benign prostatic hypertrophy (BPH) and other (...) causes of urine outflow obstruction (for example, urinary tract stones, urethral stricture). Catheterisation — UTI is the most common hospital acquired infection, and the majority of cases result from indwelling catheters. Previous urinary tract surgery. Immunocompromised state. Complications may include: Renal function impairment. Prostatitis. Pyelonephritis. Sepsis. Urinary stones. A lower UTI should be suspected if the man has: Dysuria, frequency, urgency, nocturia, and suprapubic pain. Suprapubic

2018 NICE Clinical Knowledge Summaries

87. Reducing the chance of recurrent urinary tract infection (UTI) in premenopausal women who are not pregnant

Reducing the chance of recurrent urinary tract infection (UTI) in premenopausal women who are not pregnant Decision aid for urinary tract infection (recurrent): antimicrobial prescribing © NICE 2018. All rights reserved. Subject to Notice of rights. Last updated November 2018 Page 1 of 7 Decision aid Reducing the chance of recurrent urinary tract infection (UTI) in premenopausal women who are not pregnant Information to help women and their healthcare professionals discuss the options Many (...) is available on the NICE website. Decision aid for urinary tract infection (recurrent): antimicrobial prescribing © NICE 2018. All rights reserved. Subject to Notice of rights. Last updated November 2018 Page 2 of 7 D-mannose Cranberry Antibiotic What does this option involve? D-mannose is a sugar that you buy as powder or tablets. D-mannose is taken every day. You buy cranberry as either cranberry juice, tablets or capsules. Cranberry is taken every day. If you know that something triggers a UTI you could

2018 Health Information and Quality Authority

88. Reducing the chance of recurrent urinary tract infection (UTI) in postmenopausal women

Reducing the chance of recurrent urinary tract infection (UTI) in postmenopausal women Decision aid for recurrent urinary tract infection (UTI) in postmenopausal women © NICE 2018. All rights reserved. Subject to Notice of rights. Last updated November 2018 Page 1 of 8 Decision aid Reducing the chance of recurrent urinary tract infection (UTI) in postmenopausal women Information to help women and their healthcare professionals discuss the options Many women have UTIs from time to time but some (...) and the evidence on which it is based is available on the NICE website. Decision aid for recurrent urinary tract infection (UTI) in postmenopausal women © NICE 2018. All rights reserved. Subject to Notice of rights. Last updated November 2018 Page 2 of 8 D-mannose Cranberry Vaginal oestrogen Antibiotic What does this option involve? D-mannose is a sugar that you buy as powder or tablets. D-mannose is taken every day. You buy cranberry as either cranberry juice, tablets, or capsules. Cranberry is taken every

2018 Health Information and Quality Authority

89. Urinary tract infections and bladder management over the first year after discharge from inpatient rehabilitation. Full Text available with Trip Pro

Urinary tract infections and bladder management over the first year after discharge from inpatient rehabilitation. Secondary analysis of data from a prospective clinical trial of telephone counseling.To describe changes in bladder management and development of bladder-related complications in the first year after discharge from inpatient spinal cord injury (SCI) rehabilitation. To determine whether urinary tract infection (UTI) is associated with bladder management technique or severity of SCI (...) of follow-up, 19% of patients changed bladder management techniques. Among participants performing intermittent catheterization (IC), 20% had urinary incontinence weekly or more frequently. The cumulative incidence of UTI was 71% by the end of the study, and between 27 and 46% of subjects reported UTIs during each 3-month period. Subjects with spontaneous voiding reported significantly fewer UTIs than those using IC or indwelling catheterization (IDC), but there was no significant difference in UTIs

2018 Spinal cord series and cases Controlled trial quality: uncertain

90. Xanthogranulomatous pyelonephritis with reno-colic fistula: A rare complication of urinary tract infection Full Text available with Trip Pro

Xanthogranulomatous pyelonephritis with reno-colic fistula: A rare complication of urinary tract infection Urinary tract infection (UTI) is one of the most common presentations in general practice and, in most instances, occurs in a single episode and is easily treated with a course of anti-microbial therapy. In the case of recurrent urinary tract infections, it is important to consider evaluation for any underlying causes. We report the case of a 32 year old female who had recurrent UTIs

2017 Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia

91. Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis

Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for Painful Bladder Syndrome / Interstitial Cystitis, Recurrent Urinary Tract Infection and Radiation Induced Cystitis 1 Public Summary Document Application No. 1439 – Intravesical instillation of sodium hyaluronate (1.6%) & sodium chondroitin sulphate (2.0%) for painful bladder syndrome /interstitial cystitis and recurrent urinary tract infection and radiation induced cystitis Applicant: Juno (...) syndrome (PBS)/interstitial cystitis (IC), patients with recurrent urinary tract infections (rUTIs) and patients with radiation-induced cystitis, was received by the Department of Health from Juno Pharmaceuticals Pty Ltd. 2. MSAC’s advice to the Minister MSAC agreed that painful bladder syndrome/interstitial cystitis (PBS/IC), recurrent urinary tract infections (rUTIs) and radiation induced cystitis (RIC) can be debilitating conditions and there is a place for instillation of sodium hyaluronate

2017 Medical Services Advisory Committee

92. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. Full Text available with Trip Pro

Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. Objective To investigate whether symptomatic treatment with non-steroidal anti-inflammatory drugs (NSAIDs) is non-inferior to antibiotics in the treatment of uncomplicated lower urinary tract infection (UTI) in women, thus offering an opportunity to reduce antibiotic use in ambulatory care.Design Randomised, double blind, non-inferiority trial.Setting 17 general

2017 BMJ Controlled trial quality: predicted high

93. Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection Full Text available with Trip Pro

Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection Enterococcus faecalis is a leading causative agent of catheter-associated urinary tract infection (CAUTI), the most common hospital-acquired infection. Its ability to grow and form catheter biofilm is dependent upon host fibrinogen (Fg). Examined here are how bacterial and host proteases interact with Fg and contribute to virulence. Analysis

2017 NPJ biofilms and microbiomes

94. Urinary Tract Infection. (Abstract)

Urinary Tract Infection. Urinary tract infections (UTIs) are common in both inpatient and outpatient settings. This article provides an evidence-based, clinically relevant overview of management of UTIs, including screening, diagnosis, treatment, and prevention. Conditions covered include acute cystitis (both uncomplicated and complicated), catheter-associated UTI, and asymptomatic bacteriuria in both women and men.

2017 Annals of Internal Medicine

95. Meropenem and vaborbactam (Vabomere) - To treat adults with complicated urinary tract infections

Meropenem and vaborbactam (Vabomere) - To treat adults with complicated urinary tract infections VABOMERE (meropenem and vaborbactam) Powder for Injection U.S. Department of Health and Human Services Search FDA Submit search VABOMERE (meropenem and vaborbactam) Powder for Injection VABOMERE Company: Rempex Pharmaceuticals, Inc. Application No.: 209776 Approval Date: 08/29/2017 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF

2017 FDA - Drug Approval Package

96. Probiotics for preventing urinary tract infection in people with neuropathic bladder. Full Text available with Trip Pro

Probiotics for preventing urinary tract infection in people with neuropathic bladder. Neuropathic or neurogenic bladder describes a process of dysfunctional voiding as the result of injury in the brain, spinal cord or nerves innervating the bladder. People with neuropathic bladder, such as from spinal cord injury (SCI), are at significant risk of morbidity from urinary tract infections (UTI). Effective methods to prevent UTI in people with SCI have been sought for many years. Probiotics (micro (...) -organisms that exert beneficial health effects in the host) have been recommended for bacterial interference of the urological tract to reduce colonisation by uropathogen and to manage the dual problems of infection and antibiotic resistance.This review looked at the benefits and harms of probiotics in preventing symptomatic UTI in people with neuropathic bladder compared with placebo, no therapy, or non-antibiotic prophylaxis (cranberry juice, methenamine hippurate, topical oestrogen).We searched

2017 Cochrane

97. The efficacy of D-mannose in the prevention of recurrent urinary tract infections compared to long-term antibiotic therapy

The efficacy of D-mannose in the prevention of recurrent urinary tract infections compared to long-term antibiotic therapy "The efficacy of D-mannose in the prevention of recurrent urinary tract" by Kristine Stompro < > > > > > Title Author Date of Graduation Summer 8-12-2017 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies Rights . Abstract Background: Recurrent urinary tract infections are a significant problem in women and the current mainstay (...) of prophylactic therapy is long-term antibiotic use. Based on recent studies, there is a possible natural remedy that could reduce the use of antibiotics for preventative medicine in recurrent urinary tract infections. This would decrease the chance of antibiotic resistance and the side effects of the antibiotics to the user. Methods: An exhaustive search of CINAHL, MEDLINE-Ovid, MEDLINE-PubMed, and Web of Science with the search terms “D-mannose” and “recurrent urinary tract infection” was performed

2017 Pacific University EBM Capstone Project

98. Elevated antibiotic resistance of Sudanese urinary tract infection bacteria Full Text available with Trip Pro

Elevated antibiotic resistance of Sudanese urinary tract infection bacteria This study determined the prevalence of urinary tract infections in the Sudanese state of Khartoum and antimicrobial susceptibility pattern of isolated bacterial species. 200 adult patient urine specimens were collected and cultivated to identify the growing bacteria and their susceptibility to antibiotics. 35 % of specimens had significant bacterial growth. The most frequent isolates in this study were E. coli, E

2017 EXCLI journal

99. NSAIDs as treatment for uncomplicated urinary tract infections

NSAIDs as treatment for uncomplicated urinary tract infections NSAIDs as treatment for uncomplicated urinary tract infections – Morsels of Evidence \t\t\t\r\n\t\t\t \t\t\t\r\n\t\t\t Like this: Like Loading... ","author":{"@type":"Person","name":"Michael Tam"},"image":["https:\/\/evidencebasedmedicine.com.au\/wp-content\/uploads\/2017\/06\/mo2017-5.png"]} Toggle search form Toggle navigation Evidence-based medicine for general practitioners Jun 09 2017 NSAIDs as treatment for uncomplicated (...) urinary tract infections By in , , Journal reference: Gagyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. Bmj 2015 Dec 23;351:h6544. Link: Published: December 2015 Evidence cookie says… NSAIDs should not be recommended as a first line treatment for uncomplicated UTIs in women compared with women who received empirical antibiotics, those who received regular

2017 Morsels of Evidence

100. NSAIDs as treatment for uncomplicated urinary tract infections

NSAIDs as treatment for uncomplicated urinary tract infections NSAIDs as treatment for uncomplicated urinary tract infections – Morsels of Evidence \t\t\t\r\n\t\t\t \t\t\t\r\n\t\t\t Like this: Like Loading... ","author":{"@type":"Person","name":"Michael Tam"},"image":["https:\/\/evidencebasedmedicine.com.au\/wp-content\/uploads\/2017\/06\/mo2017-5.png"]} Toggle search form Toggle navigation Evidence-based medicine for general practitioners Jun 09 2017 NSAIDs as treatment for uncomplicated (...) urinary tract infections By in , , Journal reference: Gagyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. Bmj 2015 Dec 23;351:h6544. Link: Published: December 2015 Evidence cookie says… NSAIDs should not be recommended as a first line treatment for uncomplicated UTIs in women compared with women who received empirical antibiotics, those who received regular

2017 Morsels of Evidence